- Open Access
Perianesthetic mortality in English Bulldogs: a retrospective analysis in 2010 – 2017
BMC Veterinary Research volume 18, Article number: 198 (2022)
Many veterinarians consider English Bulldogs to have a greater perianesthetic mortality risk. The aims of this study were to 1) determine total and anesthesia-related, perianesthetic mortality (PAM) rates in English Bulldogs (EB), 2) identify potential risk factors associated with mortality in EB, and 3) determine the difference in the perianesthetic mortality rates between EB, other-brachycephalic breeds (OB), and non-brachycephalic breeds (NB).
Records from EB that were anesthetized between 2010 and 2017, were investigated. OB and NB were enrolled to match with each EB based on a procedure and age from the study period. Data collected in EB included: age, ASA status, weight, procedure types, anesthetic and analgesic management, anesthetic duration, anesthetic recovery location, and cause of death. Age and cause of death were determined from OB and NB. Fisher’s exact test was used to compare PAM rate and age in EB, OB, and NB. Mann–Whitney U test was used to compare EB survivor and EB non-survivor. Logistic regression models were used to identify factors and odds ratio (OR) associated with PAM in EB.
Two hundred twenty nine EB, 218 OB, and 229 NB were identified. The total and anesthesia-related PAM rates in EB were 6.6 and 3.9%, respectively. EB had a greater total PAM rate compared with OB (p = 0.007). ASA status was different between survivors and non-survivors in EB (p < 0.01). Risk factors identified regardless of the cause of death were premedication with full μ opioids (OR = 0.333, p = 0.114), continuous infusion of ketamine post-operatively (OR = 13.775, p = 0.013), and acepromazine administration post-operatively (OR = 7.274, p = 0.004). The most common cause of death in EB was postoperative respiratory dysfunction (87.5%).
Total and anesthesia-related mortality in EB is considerable. Most deaths in EB occurred during the postoperative period secondary to respiratory complications.
Many dogs from brachycephalic breeds have anatomical abnormalities such as stenotic nares, elongated soft palate, everted laryngeal saccules, and hypoplastic trachea, which together are referred to as brachycephalic obstructive airway syndrome (BOAS). Due to these abnormalities, brachycephalic dogs were widely considered to have a greater risk of perianesthetic mortality . Recently, Gruenheid et al.  reported that brachycephalic dogs were more likely to experience perianesthetic complications compared with non-brachycephalic dogs, however brachycephaly is not a reported risk factor for perianesthetic mortality [3,4,5,6,7,8,9,10,11,12].
Confusingly, the umbrella term “brachycephalic breed”, is not standardized and each investigation includes different breeds such as; English Bulldog (EB), French Bulldog, Pug, Boston Terrier, Shih Tzu, Cavalier King Charles Spaniel, Chihuahua, and Boxer. In the authors’ experience, EB has a greater risk of perianesthetic complications including death compared with other brachycephalic breeds.
Thus, the aims of this study were 1) to determine perianesthetic mortality rate in EB, 2) to determine the difference in the perianesthetic mortality rates between EB, other brachycephalic breeds (OB), and non-brachycephalic breeds (NB), and 3) to identify risk factors associated with mortality in EB. It was hypothesized that EB have greater perianesthetic mortality rate compared with the rate in other brachycephalic breeds or non-brachycephalic breeds.
Data were collected from 229 EB with patient matches for 218 OB and 229 NB. Breeds included in OB were French Bulldog (n = 44), Pug (n = 39), Shih Tzu (n = 35), Boxer (n = 35), Boston Terrier (n = 31), Cavalier King Charles Spaniel (n = 19), and Pekingese (n = 15). These breeds were included based on their brachycephalic head conformation . Non-brachycephalic breeds are summarized in Table 1.
The median (range) age of EB, OB, and NB was 3 (0.25 – 14), 5 (0.17 – 16), and 5 (0.2 – 13) years old, respectively. EB was significantly younger than OB (p = 0.0064) or NB (p = 0.0025).
Perianesthetic mortality rates
The total mortality rate within EB (not accounting for multiple anesthetic episodes) was 6.6% with 95% confidence interval of (3.3%, 9.8%). The rate within episode (not accounting for patients receiving multiple anesthetic episodes) was 4.4% with a 95% confidence interval of 2.2%, 6.5%).
The perianesthetic mortality rates of EB, OB, and NB are shown in Table 2. Due to the lack of anesthesia-related deaths in NB, it is not possible to estimate the exact difference (odds ratio (OR) not available).
Survivors and non-survivors in English Bulldogs
Demographics of survivors and non-survivors in EB are shown in Table 3. Of the EB survivors, there were 43 intact males, 74 castrated males, 24 intact females, 71 spayed females, and one hermaphrodite. Of the EB non-survivors, there were 5 intact males, 4 castrated males, 2 intact females, and 4 spayed females.
Risk factors evaluated are shown in Table 4. For Outcome 1 (survivors vs. non-survivors), the risk factors associated with a decreased OR of death included premedication with full µ opioids (PM full μ opioids) (OR = 0.333, p = 0.114). Risk factors associated with an increased OR of death included, ketamine continuous rate infusion (CRI) during the recovery period (RM Keta CRI) (OR = 13.775, p = 0.013), or acepromazine administration during the recovery period (RM Ace) (OR = 7.274, p = 0.004).
For Outcome 2 (EB-AD, anesthesia-related deaths in EB vs. EB-ND, non-anesthetic deaths in EB), the potential risk factors identified were; whether the procedure was interventional in nature, acepromazine given in recovery (RM Ace), or gastrointestinal (GI) co-morbidity. The p-values for each of these in this model is 1 and the ORs are inestimable due to complete separation introduced by combinations of these factors.
Due to the small number of EB in each category for Outcome 3 (euthanized (n = 6) vs. cardiopulmonary arrest (CPA) (n = 9)) similar to Outcome 2, no statistical analysis was performed for Outcome 3.
Number of anesthetic episodes and procedure types
Total number of anesthetic episodes for EB (n = 229) was 344 episodes. Of these, 53 EB (50 survivors and 3 non-survivors) underwent more than one episode of anesthesia during the study period. A total of 441 procedure types were performed on EB within the following categories: respiratory (n = 78), abdominal (n = 55), interventional (n = 140), bone (n = 45), and minor procedure (n = 123). Procedure types performed on EB non-survivors (at the time of death if there were multiple anesthetic episodes) were respiratory (n = 5), abdominal (n = 3), interventional (n = 5), minor (n = 5), and bone procedures (n = 0). The number of anesthetic episodes or procedure types was not a risk factor for perianesthetic mortality in EB.
Deaths in English Bulldogs, other brachycephalic breeds, & non-brachycephalic breeds
Anesthesia related deaths in EB (n = 9) are summarized in Table 5. Six EB-AD were admitted to the hospital via the emergency service. EB-AD 2, 3, 5, 8, and 9 did not receive premedication prior to induction of anesthesia due to various clinical decisions including avoiding reduction of laryngeal motion caused by a drug during functional laryngeal exam. EB-AD 4 and 8 were anesthetized previously (during the same hospitalization) for laparotomy, and surgical correction of BOAS and temporary tracheostomy tube placement, respectively. Six of seven EB-AD were sedated with acepromazine during hospitalization. Among EB-ND (n = 6), 1 (16.7%) died intraoperatively due to fatal hemorrhage from surgical complication, and 5 (83.3%) were euthanized considering quality of life after diagnostic procedures were completed.
Two anesthesia-related deaths were noted in OB (one post-anesthetic CPA and one euthanasia due to aspiration pneumonia). One OB was euthanized for non-anesthetic related reason intraoperatively. None of the deaths in NB were anesthesia related. All NB were euthanized due to poor prognosis of their diseases.
The total perianesthetic mortality rate in EB in this study was 6.6% (15/229) of which anesthesia-related mortality rate was 3.9% (9/229). Even though there was no statistical difference between the groups for anesthesia-related mortality rates, EB (3.9%) and OB (0.92%) or NB (0%), the authors consider these percentage differences to be clinically relevant. Similarly, the total rates for perianesthetic mortality between the groups (EB: 6.6%, OB:1.4%, NB:1.8%) identified only a statistical difference between EB and OB, the authors find the percentage differences compelling. It is likely that this study is underpowered.
Brachycephalic breeds have long been suspected to have increased anesthetic risks because of brachycephaly that predispose them to develop BOAS. BOAS can result in respiratory (laryngeal collapse) and GI complications (gastroesophageal regurgitation, GER) because of greater sub-atmospheric pressure during inspiration to overcome progressive and chronic upper airway obstruction . A prospective study, which performed endoscopic examination of brachycephalic dogs with BOAS, revealed that 97.3% (71/73) had esophageal, gastric, and/or duodenal abnormalities . Conscious, unmedicated, brachycephalic canine breeds including EB have lower arterial partial pressure of oxygen and greater arterial partial pressure of carbon dioxide than non-brachycephalic breeds based on arterial blood gas analysis at rest in room air . Not surprisingly, many studies have shown that clinical signs and quality of life improve after surgical correction of BOAS; however, complete resolution of clinical signs may not occur [17,18,19,20,21]. It is postulated that preemptive correction of stenotic nares (and elongated soft palate if needed) in younger EB may delay development and progression of BOAS with understanding that the nasal resistance significantly contributes to total airway resistance . All of these anatomic and physiologic differences likely contribute the differences in mortality rate identified in this study.
Three risk factors were detected for Outcome 1, whether the dog survived to discharge, or died. Premedication with a full μ opioid was associated with a decreased OR of death. It was surprising that administration of full μ opioid as a premedication was associated with reduced risk of death in EB because, full μ opioids decrease lower esophageal sphincter pressure , increase incidence of GER in dogs , and cause nausea and vomiting , all of which can lead to aspiration. It is possible that this association may be skewed since five of eight English Bulldogs that died intentionally did not receive any premedication to facilitate surgical procedure (e.g. laryngeal function exam and Caesarian section). Therefore, it is unknown whether an “opioid-restricted” protocol would decrease mortality.
Ketamine CRI in recovery was identified as a positive risk factor mortality with an OR of 13.8. The dosage range of ketamine CRI for the dogs in this study was (2 mcg kg−1 min−1—10 mcg kg−1 min−1). At these subanesthetic dosages, respiratory depression, GI effects, or central nervous system depression would not be expected. The addition of ketamine as a CRI in the recovery period may be instituted; as part of multimodal analgesic strategy, when opioid analgesia alone is considered insufficient, or when opioid administration is limited (e.g. by surgeon request). Thus, it is possible that a dog receiving ketamine might have very high analgesic needs which could result in robust dosing of drugs which could result in excessive sedation. Alternatively, if requested to limit opioid use, an anesthetist may choose to use a ketamine CRI to help with pain management. Unfortunately, the retrospective design of this project makes it impossible to know the reasons for ketamine CRI administration and thus this study cannot determine how addition of ketamine CRI was associated with an increased perianesthetic mortality rate in EB.
Administration of acepromazine during recovery was also associated with an increased mortality risk, with an OR of 7.3. Acepromazine is a dopamine receptor antagonist, used for sedation. It has a long elimination half-life (7.1 h) in dogs  and is commonly used in veterinary medicine for patients requiring long duration sedation. Acepromazine is often recommended to patients with respiratory distress . Alternatively, acepromazine is administered with full μ opioids to produce neurolept-analgesia, which increases the analgesia produced by the opioid. As with the ketamine CRI, it is impossible to retrospectively evaluate the decision to administer this drug. While acepromazine does not cause significant respiratory depression or GI complications , it is possible that increased laryngeal muscle relaxation in dogs with GER, increased the risks of aspiration.
Outcome 2 evaluated the risk of death in EB from anesthesia related vs non-anesthesia related causes. While risk factors were identified (GI comorbidity, interventional procedures, and acepromazine given during recovery) the model was unable to provide OR. Statistically, this suggests that the sample size in each group was too small (underpowered) to estimate relative probability with confidence. In addition to implicated risk factors identified, all EB-AD in this study had pre-existing respiratory comorbidity (BOAS, exercise intolerance, respiratory distress, or history of aspiration pneumonia). To the authors’ knowledge, no study has evaluated this question to date.
In addition to the risk factors assessed in this study, there are other factors that might contribute to anesthetic risk that could not be evaluated via a retrospective study. It is likely that the severity of BOAS is a risk factor, but only 27% of dogs had a complete upper airway evaluation. Comparison of severity of BOAS with morbidity and mortality associated with anesthesia would likely be informative. Similarly, other anatomical abnormalities reported in EB, such as protrusion of nasopharyngeal turbinate , bronchial collapse , or the incidence of GER was unknown in most of the EB in this study.
Another risk factor, which was not evaluated in the current study, is pharyngeal myopathy. English Bulldogs have been studied as a natural model for obstructive sleep apnea in humans, and structural as well as functional changes in upper airway dilator muscles due to chronic obstructive respiration have been documented on histopathology , magnetic resonance imaging , and electromyography . The sequela of the myopathy is decreased activity of upper airway dilator muscles during sleep, especially during rapid eye movement (REM) sleep, and this contributes to upper airway obstruction and hypoxemia. The effect of general anesthesia or common drugs used during a perianesthetic period on the activity of these muscles is unclear. Presence and severity of pharyngeal myopathy in other brachycephalic dogs have not been studied. Finally, it is possible that this is a complex subject with many factors involved, such that data from 229 EB may be too small to determine multiple risk factors for the greater perianesthetic mortality rate.
The result from the current study suggests that American Society of Anesthesiologists (ASA) physical status is not a good predictor for perianesthetic survival in EB. When EB survivors and non-survivors were compared, ASA physical status was found to be lower in survivors. Increasing ASA physical status has repeatedly been associated with mortality [3, 4, 7,8,9,10, 12] including one study specifically looking at brachycephalic breeds . One possible reason that EB had higher mortality with lower ASA status is that many EB with moderate to severe BOAS have surgery to correct the airway defects early in life. These dogs are generally young and metabolically healthy, so are often assigned a low ASA score, even though the risks associated with their airways and GER likely place them at higher risk than is recorded. There is significant interobserver variability  when assigning ASA physical status.
Most EB that had anesthetic related deaths, 7/8 were caused by sequelae from respiratory complications within 48 h of postoperative period. While these findings were not statistically significant, the authors find the results clinically relevant. Gross regurgitation was observed in 4 of EB-AD, but it is possible that silent GER also occurred. There is an association between upper airway obstruction and GER , and a recent study reported that the prevalence of anesthetic GER detected with esophageal pH probe was 60% (12/20) in brachycephalic dogs . The administration of prokinetic drugs in 7/9 of EB did not appear to prevent mortality, nor was it identified as a risk factor. It is also possible that an acute upper airway obstruction had led to GER and caused aspiration pneumonia during hospitalization.
Ages of EB and NB were different, even with the efforts to match the cases. Since the procedure was considered the first priority in matching cases (e.g. airway surgery), this likely explains the difference. Laryngeal tieback surgery is more commonly performed in older NB whereas surgical correction of BOAS is performed in younger EB.
Multiple limitations exist in this study. First, because this was a retrospective study, perianesthetic management was not controlled, and management decisions from different clinicians may have affected the data. Clinician based decisions include; recovery location (i.e. some clinicians keep EB in an oxygen cage during recovery regardless of clinical need), pro-kinetic drugs, full vs partial mu opioids, etc.). As with all retrospective clinical studies, some data was missing, and the validity of the study is reliant on the accurateness of the information in the record (e.g. cause of death, severity of disease, etc.). Second, over 20% (53/229) of EB had multiple anesthetic episodes during the study period, and data were combined to include one original dog for statistical analysis. Furthermore, some factors, such as procedures and co-morbidities, were categorized for the same reason. These data handling made the interpretation of results more difficult. Interestingly, however, the number of anesthetic episodes was not identified as a risk factor. Third, because multiple procedures were performed within one anesthetic episode for many EB, a respiratory procedure was chosen as the priority for matching with NB to compare the perianesthetic mortality rates. This could have caused bias because EB is already compromised regarding its upper respiratory system compared with NB. In addition, matched NB and OB may have had other procedures performed or had multiple anesthetic episodes during the study period. Fourth, because more EB had surgical correction of BAOS, other upper airways surgeries were chosen for the match. These procedures are likely not equivalent. Fifth, data were collected from only one veterinary teaching hospital in the United States. Clinical styles develop at institutions for anesthesia, surgery, recovery, intensive care unit (ICU) etc. It is unknown if these results reflect the risk of EB anesthesia elsewhere. Finally, although approximately 7-year-worth of data were collected, sample size may be too small to identify a risk factor (type II error).
In conclusion, the total and anesthesia-related perianesthetic mortality rates in English Bulldogs at a veterinary teaching hospital were 6.6% and 3.9%, respectively. However, anesthesia-related perianesthetic mortality rates between English Bulldogs and other brachycephalic dogs or non-brachycephalic dogs were not statistically different. Almost all English Bulldogs that suffered anesthetic related deaths had respiratory complications in the postoperative period. Only ASA physical status was found to be different between survivors and non-survivors in English Bulldogs. Full mu opioids were associated with less mortality in EB, whereas a constant rate infusion of ketamine or administration of acepromazine during a recovery period was associated with increased mortality in EB.
Material and methods
Medical records at North Carolina State University Veterinary Teaching Hospital from January 1, 2010 to September 30, 2017, were examined, using an integrated computer search program, to identify any dog labeled as purebred EB. All EB were included if they were anesthetized during the study period. For comparison, a non-brachycephalic group (NB) and an other-brachycephalic group (OB) were created by enrolling animals from the same study period and matched with each EB based on a procedure (the first priority) and age (the second priority). If EB underwent multiple procedures within one anesthetic episode, any airway procedure was considered as the first priority for the match. Because many cases for surgical correction of BOAS were performed in EB, other upper airway procedures, such as cricoarytenoid lateralization (tieback), cleft palate repair, tonsillectomy, and soft palate or laryngeal mass removal, were used as procedure matches with surgical correction of BOAS in NB and OB. If no respiratory procedure was involved, NB and OB were matched with EB based on the most invasive procedure performed. If the exact procedure could not be matched, a procedure with similar invasiveness was chosen. Both NB and OB may have had other procedures performed during the same anesthetic episode.
From each EB, the following data were collected by reviewing electronic and hand-written records: age, sex, weight, the ASA physical status, emergency status at admission, duration of anesthesia, number of anesthetic episodes within the period for data collection, procedures, co-morbidities, status of pregnancy, anesthetic drugs administered throughout an anesthetic episode and during recovery period, GI drugs administered, interventions for hypotension, recovery location after anesthesia, use of oxygen cage during hospitalization, notation of regurgitation at home or during hospitalization, use of suction in the upper GI tract, and use of corticosteroid. For statistical analysis, procedures were categorized into 5 categories (respiratory, abdominal, interventional, bone, and minor), and an additional file shows the categorization in more detail [see Additional file 1: Appendix 1]. Categorization was also performed on co-morbidities (respiratory, cardiovascular, GI, and neurologic), opioid type (full µ opioids vs. non-full µ opioids), GI drug use (anti-nausea, prokinetic, and antacid), interventions for hypotension (fluid therapy, anticholinergic, inotropic, and vasopressor), and recovery location. Recovery location after anesthesia was categorized based on the level of care unit; continuously monitored (ICU, intermediate care unit, and emergency service) and intermittently monitored (general wards).
Three mortality outcomes were evaluated. Outcome 1 assessed whether the EB patient was discharged from hospital (survivor) or died during hospitalization (non-survivors) regardless of the cause of death. Outcome 2 assessed whether the EB patient died from a cause related to anesthesia (EB-AD) or died from a cause unrelated to anesthesia (EB-ND). Anesthesia-related death was considered as a death within 48 h after an anesthetic event unless a specific reason of the death unrelated to anesthesia was noted. Outcome 3 assessed whether the EB patient was euthanized or experienced CPA. If a dog had more than one episode of anesthesia, data were combined and reported as one dog. An average was determined for each numerical variable such as age and weight. If different anesthetic protocols were used or different procedures were performed on the same EB, all interventions and procedures were included even though they were not performed during the same anesthetic episode.
For each dog in the NB and OB groups, age and Outcome 1 and 2 were identified.
Statistical analysis was performed using two different commercially available statistical software programs (GraphPad Prism 8, GraphPad Software Inc., CA, USA; R version 4.0.2, R Foundation for Statistical Computing, Vienna, Austria). The p-value was set as 0.05 or less unless specified. Numerical data were tested for normality with D'Agostino-Pearson normality test, and parametric data were reported with mean ± standard deviation (SD) whereas nonparametric data were reported with median (range). Mann–Whitney U test was used to compare characteristics of survivors and non-survivors in EB.
To estimate the perianesthetic mortality rate, a normal confidence interval was constructed around the point estimate. To examine potential risk factors, the selected variables were examined one-by-one with logistic regression then all variables with a p-value less than 0.10 were included in a full model for survival and a p-value less than 0.20 was considered sufficient when looking at anesthesia-related death. The full model was reduced by use of the Bayes’ Information Criteria. To compare mortality rates between EB, NB, and OB, Fisher’s exact test was used, and p-value was set as 0.01 to correct for multiple testing and keep the α rate at 0.05.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Brachycephalic obstructive airway syndrome
Non-brachycephalic comparison group
Other-brachycephalic comparison group
American Society of Anesthesiologists
English Bulldogs died from anesthesia-related causes
English Bulldogs died from non-anesthetic causes
Constant rate infusion
Rapid eye movement
Fawcett A, Barrs V, Awad M, et al. Consequences and management of canine brachycephaly in veterinary practice: perspectives from Australian veterinarians and veterinary specialists. Animals (Basel). 2019. https://doi.org/10.3390/ani9010003.
Gruenheid M, Aarnes TK, McLoughlin MA, Simpson EM, Mathys DA, Mollenkopf DF, et al. Risk of anesthesia-related complications in brachycephalic dogs. J Am Vet Med Assoc. 2018;253:301–6.
Clarke KW, Hall LW. A survey of anaesthesia in small animal practice: AVA/BSAVA report. J Ass Vet Anaesth. 1990. https://doi.org/10.1111/j.1467-2995.1990.tb00380.x.
Dyson DH, Maxie MG, Schnurr D. Morbidity and mortality associated with anesthetic management in small animal veterinary practice in Ontario. J Am Anim Hosp Assoc. 1998;34(4):325–35.
Gaynor JS, Dunlop CI, Wagner AE, Wertz EM, Golden AE, Demme WC. Complications and mortality associated with anesthesia in dogs and cats. J Am Anim Hosp Assoc. 1999;35:13–7.
Joubert KE. Routine veterinary anaesthetic management practices in South Africa. J S Afr Vet Assoc. 2000;71(3):166–72.
Brodbelt DC, Blissitt KJ, Hammond RA, Neath PJ, Young LE, Pfeiffer DU, et al. The risk of death: the confidential enquiry into perioperative small animal fatalities. Vet Anaesth Analg. 2008;35:365–73.
Bille C, Auvigne V, Libermann S, Bomassi E, Durieux P, Rattez E. Risk of anaesthetic mortality in dogs and cats: an observational cohort study of 3546 cases. Vet Anaesth Analg. 2012;39:59–68.
Gil L, Redondo JI. Canine anaesthetic death in Spain: a multicenter prospective cohort study of 2012 cases. Vet Anaesth Analg. 2013;40(6):e57-67.
Itami T, Aida H, Asakawa M, Fujii Y, Iizuka T, Imai A, et al. Association between preoperative characteristics and risk of anaesthesia-related death in dogs in small-animal referral hospitals in Japan. Vet Anaesth Analg. 2017;44:461–72.
Matthews NS, Mohn TJ, Yang M, Spofford N, Marsh A, Faunt K, et al. Factors associated with anesthetic-related death in dogs and cats in primary care veterinary hospitals. J Am Vet Med Assoc. 2017;250:655–65.
Smith MD, Barletta M, Young CN, Hofmeister EH. Retrospective study of intra-anesthetic predictors of prolonged hospitalization, increased cost of care and mortality for canine patients at a veterinary teaching hospital. Vet Anaesth Analg. 2017;44:1321–31.
Packer RMA, Hendricks A, Tivers MS, Burn CC. Impact of facial conformation on canine health: brachycephalic obstructive airway syndrome. PLoS one. 2015;10(10):e0137496. https://doi.org/10.1371/journal.pone.0137496.
Robinson NE. Airway physiology. Vet Clin North Am Small Anim Pract. 1992;22(5):1043–64.
Poncet CM, Dupre GP, Freiche VG, Estrada MM, Poubanne YA, Bouny BM. Prevalence of gastrointestinal tract lesions in 73 brachycephalic dogs with upper respiratory syndrome. J Small Anim Pract. 2005;46(6):273–9.
Hoareau GL, Jourdan G, Mellema M, Verwaerde P. Evaluation of arterial blood gases and arterial blood pressures in brachycephalic dogs. J Vet Intern Med. 2012;26:897–904.
Poncet CM, Dupre GP, Freiche VG, Bouvy BM. Long-term results of upper respiratory syndrome surgery and gastrointestinal tract medical treatment in 51 brachycephalic dogs. J Small Anim Pract. 2006;47:137–42.
Torrez CV, Hunt GB. Results of surgical correction of abnormalities associated with brachycephalic airway obstruction syndrome in dogs in Australia. J Small Anim Pract. 2006;47:150–4.
Riecks TW, Birchard SJ, Stephens JA. Surgical correction of brachycephalic syndrome in dogs: 62 cases (1991–2004). J Am Vet Med Assoc. 2007;230:1324–8.
De Lorenzi D, Bertoncello D, Drigo M. Bronchial abnormalities found in a consecutive series of 40 brachycephalic dogs. J Am Vet Med Assoc. 2009;235:835–40.
Haimel G, Dupre G. Brachycephalic airway syndrome: a comparative study between pugs and French bulldogs. J Small Anim Pract. 2015;56:714–9.
Ohnish T, Ogura JH. Partitioning of pulmonary resistance in the dog. Laryngoscope. 1969;79(11):1847–78.
Hall AW, Moosa AR, Clark J, Cooley GR, Skinner DB. The effects of premedication drugs on the lower oesophageal high pressure zone and reflux status of Rhesus monkeys and man. Gut. 1975;16:347–52.
Wilson DV, Evans AT, Miller R. Effects of preanesthetic administration of morphine on gastroesophageal reflux and regurgitation during anesthesia in dogs. Am J Vet Res. 2005;66:386–90.
Kukanich B, Papich MG. Opioid analgesic drugs. In: Riviere JE, Papich MG, editors. Veterinary pharmacology and therapeutics. Hoboken: Wiley-Blackwell; 2009. p. 301–36.
Posner LP, Burns P. Sedative agents: Tranquilizers, alpha-2 agonists, and related agents. In: Riviere JE, Papich MG, editors. Veterinary pharmacology and therapeutics. Hoboken: Wiley-Blackwell; 2009. p. 337–80.
Clarke DL. Upper airway disease. In: Silverstein DC, Hopper K, editors. Small animal critical care medicine. Elsevier; 2014. p. 92–104.
Ginn JA, Kumar MSA, McKiernan BC, Powers BE. Nasopharyngeal turbinates in brachycephalic dogs and cats. J Am Anim Hosp Assoc. 2008;44:243–9.
Petrof BJ, Pack AI, Kelly AM, Eby J, Hendricks JC. Pharyngeal myopathy of loaded upper airway in dogs with sleep apnea. J Appl Physiol. 1994;76(4):1746–52.
Schotland HM, Insko EK, Panckeri KA, Leigh JS, Pack AI, Hendricks JC. Quantitative magnetic resonance imaging of upper airway musculature in an animal model of sleep apnea. J Appl Physiol. 1996;81(3):1339–46.
Hendricks JC, Kline LR, Kovalski RJ, O’Brien JA, Morrison AR, Pack AI. The English bulldog: a natural model of sleep-disordered breathing. J Appl Physiol. 1987;63(4):1344–50.
McMillan M, Brearley J. Assessment of the variation in American society of anaesthesiologists physical status classification assignment in small animal anaesthesia. Vet Anaesth Analg. 2013;40:229–36.
Wang W, Tovar JA, Eizaguirre I, Aldazabal P. Airway obstruction and gastroesophageal reflux: an experimental study on the pathogenesis of this association. J Pediatr Surg. 1993;28(8):995–8.
Shaver SL, Barbur LA, Jimenez DA, Brainard BM, Cornell KK, Radlinsky MG, et al. Evaluation of gastroesophageal reflux in anesthetized dogs with brachycephalic syndrome. J Am Anim Hosp Assoc. 2017;53(1):24–31.
The authors thank the members of Medical Record Service at North Carolina State University College of Veterinary Medicine for their support on collecting medical records of the patients for data collection.
No funding was provided for this study.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Oda, A., Wang, W.H., Hampton, A.K. et al. Perianesthetic mortality in English Bulldogs: a retrospective analysis in 2010 – 2017. BMC Vet Res 18, 198 (2022). https://doi.org/10.1186/s12917-022-03301-9
- English Bulldog
- Peri-anesthetic mortality
- Obstructive airway
- Veterinary anesthesia